Othman Sawaf-Al

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026

Remission with residuals, but no cure.

Remission with residuals, but no cure.

Journal: Blood advances
Published: June 12, 2026

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Journal: Leukemia
Published: May 10, 2026

Title Not Found

Title Not Found

Journal: Innere Medizin (Heidelberg, Germany)
Published: April 21, 2026

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Censoring imbalances in randomized first-line trials of chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: March 17, 2026

Fixed-duration vs continuous treatment for chronic lymphocytic leukemia in the CLL17 trial.

Fixed-duration vs continuous treatment for chronic lymphocytic leukemia in the CLL17 trial.

Journal: Clinical advances in hematology & oncology : H&O
Published: February 20, 2026

Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry.

Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry.

Journal: European journal of haematology
Published: December 12, 2025

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Journal: The New England journal of medicine
Published: December 08, 2025

ELEVATE-ing clinical trial reporting in CLL.

ELEVATE-ing clinical trial reporting in CLL.

Journal: Blood
Published: September 11, 2025

MURANO's final conclusions: what we've learned, what's next?

MURANO's final conclusions: what we've learned, what's next?

Journal: Blood
Published: June 05, 2025

The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia.

The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia.

Journal: Blood
Published: May 08, 2025

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.

The landscape and evolution of clonal hematopoiesis in chronic lymphocytic leukemia.

Journal: Blood
Published: May 08, 2025
Showing 1-12 of 79

Last Updated: 09/26/2026